Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France
Primary reasons for switch were treatment simplification and tolerability. Participants with obesity were more likely to switch to doravirine, reflecting physicians' favorable perception of doravirine potential benefits, particularly in managing weight gain.
Authors
- Philippe Mariot
- Laurence Slama (ORCID: https://orcid.org/0000-0002-9871-6036)
- Valérie Pourcher (ORCID: https://orcid.org/0000-0002-3879-1480)
- Bruno Spire (ORCID: https://orcid.org/0000-0002-3546-8020)
- Paul Loubet (ORCID: https://orcid.org/0000-0002-1218-9432)
- Christia Palacios
- Christine Jacomet
- Jean-Jacques Parienti
- Olivier Robineau
- Haydar Benachir
Institutions
- Inserm (FR)
- Aix-Marseille Université (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre Hospitalier Universitaire de Nîmes (FR)
- Centre Hospitalier de Tourcoing (FR)
- Pitié-Salpêtrière Hospital (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- Hôtel-Dieu de Paris (FR)
- Economic & Social Sciences, Health Systems & Medical Informatics (FR)
- Institut de Recherche pour le Développement (FR)
- Hôpital Tenon (FR)
- Université de Caen Normandie (FR)
Publication Details
- Journal
- AIDS
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1097/qad.0000000000004118
- Citations
- 7
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 9.77